• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

AF4和AF4-MLL介导1,25-二羟基维生素D3对5-脂氧合酶mRNA的转录延伸。

AF4 and AF4-MLL mediate transcriptional elongation of 5-lipoxygenase mRNA by 1, 25-dihydroxyvitamin D3.

作者信息

Ahmad Khalil, Scholz Bastian, Capelo Ricardo, Schweighöfer Ilona, Kahnt Astrid Stefanie, Marschalek Rolf, Steinhilber Dieter

机构信息

Institute of Pharmaceutical Chemistry / ZAFES, Goethe University Frankfurt, Frankfurt, Germany.

Institute of Pharmaceutical Biology / ZAFES, Goethe University Frankfurt, Frankfurt, Germany.

出版信息

Oncotarget. 2015 Sep 22;6(28):25784-800. doi: 10.18632/oncotarget.4703.

DOI:10.18632/oncotarget.4703
PMID:26329759
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4694866/
Abstract

The human 5-lipoxygenase (5-LO), encoded by the ALOX5 gene, is the key enzyme in the formation of pro-inflammatory leukotrienes. ALOX5 gene transcription is strongly stimulated by calcitriol (1α, 25-dihydroxyvitamin D3) and TGFβ (transforming growth factor-β). Here, we investigated the influence of MLL (activator of transcript initiation), AF4 (activator of transcriptional elongation) as well as of the leukemogenic fusion proteins MLL-AF4 (ectopic activator of transcript initiation) and AF4-MLL (ectopic activator of transcriptional elongation) on calcitriol/TGFβ-dependent 5-LO transcript elongation. We present evidence that the AF4 complex directly interacts with the vitamin D receptor (VDR) and promotes calcitriol-dependent ALOX5 transcript elongation. Activation of transcript elongation was strongly enhanced by the AF4-MLL fusion protein but was sensitive to Flavopiridol. By contrast, MLL-AF4 displayed no effect on transcriptional elongation. Furthermore, HDAC class I inhibitors inhibited the ectopic effects caused by AF4-MLL on transcriptional elongation, suggesting that HDAC class I inhibitors are potential therapeutics for the treatment of t(4;11)(q21;q23) leukemia.

摘要

由ALOX5基因编码的人类5-脂氧合酶(5-LO)是促炎性白三烯形成过程中的关键酶。维生素D3(1α,25-二羟基维生素D3)和转化生长因子-β(TGFβ)可强烈刺激ALOX5基因转录。在此,我们研究了转录起始激活因子MLL、转录延伸激活因子AF4以及致白血病融合蛋白MLL-AF4(转录起始异位激活因子)和AF4-MLL(转录延伸异位激活因子)对维生素D3/TGFβ依赖性5-LO转录延伸的影响。我们提供的证据表明,AF4复合物直接与维生素D受体(VDR)相互作用,并促进维生素D3依赖性ALOX5转录延伸。AF4-MLL融合蛋白可强烈增强转录延伸的激活作用,但对黄酮哌啶醇敏感。相比之下,MLL-AF4对转录延伸无影响。此外,I类组蛋白去乙酰化酶(HDAC)抑制剂可抑制AF4-MLL对转录延伸产生的异位效应,这表明I类HDAC抑制剂可能是治疗t(4;11)(q21;q23)白血病的潜在疗法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af47/4694866/5eaa8e897b32/oncotarget-06-25784-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af47/4694866/06bfa9e05cbd/oncotarget-06-25784-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af47/4694866/431679e929b1/oncotarget-06-25784-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af47/4694866/4ee70aac3f8b/oncotarget-06-25784-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af47/4694866/3ca4f2292a54/oncotarget-06-25784-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af47/4694866/e0b8e4b80a17/oncotarget-06-25784-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af47/4694866/d02578233e63/oncotarget-06-25784-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af47/4694866/16af3aff2871/oncotarget-06-25784-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af47/4694866/c7c35b2b11cc/oncotarget-06-25784-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af47/4694866/6afcfdebd7e0/oncotarget-06-25784-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af47/4694866/5eaa8e897b32/oncotarget-06-25784-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af47/4694866/06bfa9e05cbd/oncotarget-06-25784-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af47/4694866/431679e929b1/oncotarget-06-25784-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af47/4694866/4ee70aac3f8b/oncotarget-06-25784-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af47/4694866/3ca4f2292a54/oncotarget-06-25784-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af47/4694866/e0b8e4b80a17/oncotarget-06-25784-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af47/4694866/d02578233e63/oncotarget-06-25784-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af47/4694866/16af3aff2871/oncotarget-06-25784-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af47/4694866/c7c35b2b11cc/oncotarget-06-25784-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af47/4694866/6afcfdebd7e0/oncotarget-06-25784-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af47/4694866/5eaa8e897b32/oncotarget-06-25784-g010.jpg

相似文献

1
AF4 and AF4-MLL mediate transcriptional elongation of 5-lipoxygenase mRNA by 1, 25-dihydroxyvitamin D3.AF4和AF4-MLL介导1,25-二羟基维生素D3对5-脂氧合酶mRNA的转录延伸。
Oncotarget. 2015 Sep 22;6(28):25784-800. doi: 10.18632/oncotarget.4703.
2
TGFβ/SMAD signalling modulates MLL and MLL-AF4 mediated 5-lipoxygenase promoter activation.转化生长因子β/信号转导分子母亲抗五肢瘫蛋白信号传导调节混合谱系白血病蛋白和混合谱系白血病蛋白- AF4介导的5-脂氧合酶启动子激活。
Prostaglandins Other Lipid Mediat. 2017 Nov;133:60-67. doi: 10.1016/j.prostaglandins.2017.07.006. Epub 2017 Aug 11.
3
The heterodimerization domains of MLL-FYRN and FYRC--are potential target structures in t(4;11) leukemia.MLL-FYRN 和 FYRC 的异二聚化结构域是 t(4;11) 白血病的潜在靶标结构。
Leukemia. 2011 Apr;25(4):663-70. doi: 10.1038/leu.2010.308. Epub 2011 Jan 14.
4
AF4 uses the SL1 components of RNAP1 machinery to initiate MLL fusion- and AEP-dependent transcription.AF4利用RNA聚合酶I机制的SL1组件来启动依赖于MLL融合和AEP的转录。
Nat Commun. 2015 Nov 23;6:8869. doi: 10.1038/ncomms9869.
5
The mixed lineage leukemia (MLL) fusion-associated gene AF4 promotes CD133 transcription.混合谱系白血病(MLL)融合相关基因 AF4 促进 CD133 转录。
Cancer Res. 2012 Apr 15;72(8):1929-34. doi: 10.1158/0008-5472.CAN-11-3589. Epub 2012 Feb 14.
6
Molecular characterization of a rare MLL-AF4 (MLL-AFF1) fusion rearrangement in infant leukemia.婴儿白血病中一种罕见的MLL-AF4(MLL-AFF1)融合重排的分子特征
Cancer Genet Cytogenet. 2007 Oct 1;178(1):61-4. doi: 10.1016/j.cancergencyto.2007.05.023.
7
The AF4.MLL fusion protein is capable of inducing ALL in mice without requirement of MLL.AF4.AF4.MLL 融合蛋白能够在无需 MLL.AF4 的情况下诱导小鼠发生 ALL。
Blood. 2010 Apr 29;115(17):3570-9. doi: 10.1182/blood-2009-06-229542. Epub 2010 Mar 1.
8
Function of leukemogenic mixed lineage leukemia 1 (MLL) fusion proteins through distinct partner protein complexes.通过不同的伙伴蛋白复合物发挥白血病混合谱系白血病 1 (MLL) 融合蛋白的功能。
Proc Natl Acad Sci U S A. 2011 Sep 20;108(38):15751-6. doi: 10.1073/pnas.1111498108. Epub 2011 Sep 6.
9
Crosstalk between 14-3-3θ and AF4 enhances MLL-AF4 activity and promotes leukemia cell proliferation.14-3-3θ 与 AF4 之间的串扰增强了 MLL-AF4 的活性,并促进了白血病细胞的增殖。
Cell Oncol (Dordr). 2019 Dec;42(6):829-845. doi: 10.1007/s13402-019-00468-6. Epub 2019 Sep 6.
10
Cooperative gene activation by AF4 and DOT1L drives MLL-rearranged leukemia.AF4和DOT1L协同激活基因驱动MLL重排白血病。
J Clin Invest. 2017 May 1;127(5):1918-1931. doi: 10.1172/JCI91406. Epub 2017 Apr 10.

引用本文的文献

1
MLL-AF4 upregulates 5-lipoxygenase expression in t(4;11) leukemia cells via the ALOX5 core promoter.MLL-AF4通过ALOX5核心启动子上调t(4;11)白血病细胞中5-脂氧合酶的表达。
Front Pharmacol. 2025 Jan 14;15:1520507. doi: 10.3389/fphar.2024.1520507. eCollection 2024.
2
Selective inhibition of HDAC class IIA as therapeutic intervention for KMT2A-rearranged acute lymphoblastic leukemia.选择性抑制 HDAC ⅡA 类作为治疗 KMT2A 重排急性淋巴细胞白血病的方法。
Commun Biol. 2024 Oct 4;7(1):1257. doi: 10.1038/s42003-024-06916-w.
3
The role of human 5-Lipoxygenase (5-LO) in carcinogenesis - a question of canonical and non-canonical functions.

本文引用的文献

1
Inhibition of class I HDACs abrogates the dominant effect of MLL-AF4 by activation of wild-type MLL.抑制I类组蛋白去乙酰化酶(HDACs)可通过激活野生型混合谱系白血病蛋白(MLL)消除MLL-AF4的显性作用。
Oncogenesis. 2014 Nov 17;3(11):e127. doi: 10.1038/oncsis.2014.39.
2
The MLL recombinome of acute leukemias in 2013.2013 年急性白血病的 MLL 重排组。
Leukemia. 2013 Nov;27(11):2165-76. doi: 10.1038/leu.2013.135. Epub 2013 Apr 30.
3
RUNX1 is a key target in t(4;11) leukemias that contributes to gene activation through an AF4-MLL complex interaction.
人类 5-脂氧合酶(5-LO)在致癌作用中的作用——规范和非规范功能的问题。
Oncogene. 2024 May;43(18):1319-1327. doi: 10.1038/s41388-024-03016-1. Epub 2024 Apr 4.
4
Rare and Novel Fusion Genes in Pediatric T-cell Acute Lymphoblastic Leukemia.儿科 T 细胞急性淋巴细胞白血病中的罕见和新型融合基因。
Cancer Genomics Proteomics. 2021 Mar-Apr;18(2):121-131. doi: 10.21873/cgp.20247.
5
Enhanced hemato-endothelial specification during human embryonic differentiation through developmental cooperation between and fusions.通过 和 融合体在人类胚胎分化过程中的发育合作,增强了造血内皮细胞的特化。
Haematologica. 2019 Jun;104(6):1189-1201. doi: 10.3324/haematol.2018.202044. Epub 2019 Jan 24.
6
Molecular processes involved in B cell acute lymphoblastic leukaemia.B 细胞急性淋巴细胞白血病涉及的分子过程。
Cell Mol Life Sci. 2018 Feb;75(3):417-446. doi: 10.1007/s00018-017-2620-z. Epub 2017 Aug 17.
RUNX1 是 t(4;11) 白血病的关键靶点,通过 AF4-MLL 复合物相互作用促进基因激活。
Cell Rep. 2013 Jan 31;3(1):116-27. doi: 10.1016/j.celrep.2012.12.016. Epub 2013 Jan 24.
4
The super elongation complex (SEC) family in transcriptional control.转录控制中的超级延伸复合物(SEC)家族。
Nat Rev Mol Cell Biol. 2012 Sep;13(9):543-7. doi: 10.1038/nrm3417. Epub 2012 Aug 16.
5
Connectivity mapping identifies HDAC inhibitors for the treatment of t(4;11)-positive infant acute lymphoblastic leukemia.连通映射鉴定组蛋白去乙酰化酶抑制剂治疗 t(4;11)阳性婴儿急性淋巴细胞白血病。
Leukemia. 2012 Apr;26(4):682-92. doi: 10.1038/leu.2011.278. Epub 2011 Oct 21.
6
Inhibitors of histone deacetylases: correlation between isoform specificity and reactivation of HIV type 1 (HIV-1) from latently infected cells.组蛋白去乙酰化酶抑制剂:与潜伏感染细胞中 HIV 型 1(HIV-1)再激活的同种型特异性相关性。
J Biol Chem. 2011 Jun 24;286(25):22211-8. doi: 10.1074/jbc.M110.180224. Epub 2011 Apr 29.
7
The leukemogenic AF4-MLL fusion protein causes P-TEFb kinase activation and altered epigenetic signatures.白血病相关的 AF4-MLL 融合蛋白导致 P-TEFb 激酶的激活和表观遗传特征的改变。
Leukemia. 2011 Jan;25(1):135-44. doi: 10.1038/leu.2010.249. Epub 2010 Oct 29.
8
Mixed lineage leukemia: roles in human malignancies and potential therapy.混合谱系白血病:在人类恶性肿瘤中的作用和潜在治疗方法。
FEBS J. 2010 Apr;277(8):1822-31. doi: 10.1111/j.1742-4658.2010.07608.x. Epub 2010 Mar 4.
9
The AF4.MLL fusion protein is capable of inducing ALL in mice without requirement of MLL.AF4.AF4.MLL 融合蛋白能够在无需 MLL.AF4 的情况下诱导小鼠发生 ALL。
Blood. 2010 Apr 29;115(17):3570-9. doi: 10.1182/blood-2009-06-229542. Epub 2010 Mar 1.
10
AFF4, a component of the ELL/P-TEFb elongation complex and a shared subunit of MLL chimeras, can link transcription elongation to leukemia.AFF4,ELLE/P-TEFb 延伸复合物的一个组成部分和 MLL 嵌合体的一个共享亚基,可将转录延伸与白血病联系起来。
Mol Cell. 2010 Feb 12;37(3):429-37. doi: 10.1016/j.molcel.2010.01.026.